EBS

Emergent Biosolutions Stock Analysis

AI Rating

Great
  • Quality3/10
  • Growth↑ 8/10
  • Value↑ 9/10
Emergent Biosolutions sales and earnings growth
EBS Growth
Good
  • Revenue Y/Y↓ -28.81%
  • EPS Y/Y↑ 127.22%
  • FCF Y/Y↑ 346.22%
Emergent Biosolutions gross and profit margin trends
EBS Profitability
Fair
  • Gross margin ↑ 56.10%
  • EPS margin↓ 7.10%
  • ROIC 5Y↓ -13.40%
Emergent Biosolutions net debt vs free cash flow
EBS Risk
Good
  • Debt / Equity↓ 1.1
  • Debt / FCF↓ 1.9
  • Interest coverage↓ 2.4

Emergent Biosolutions stock volatility is higher than the overall market. We give it a Good risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗